Formulation comprising 1 H - quinazoline - 2, 4 - dione AMPA receptor antagonists, in the form of immediate release tablets and preparation thereof

Details for Australian Patent Application No. 2010336510 (hide)

Owner Novartis AG

Inventors Zielinski, Joseph Lawrence; Vrettos, John; Ji, Qin; Patel, Subash

Agent Davies Collison Cave

Pub. Number AU-A-2010336510

PCT Pub. Number WO2011/079119

Priority 61/288,985 22.12.09 US

Filing date 21 December 2010

Wipo publication date 30 June 2011

International Classifications

A61K 9/14 Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 9/16 Medicinal preparations characterised by special physical form - Agglomerates

A61K 9/20 Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 31/517 - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61P 25/08 Drugs for disorders of the nervous system

A61P 25/16 Drugs for disorders of the nervous system

A61P 25/18 Drugs for disorders of the nervous system

A61P 25/24 Drugs for disorders of the nervous system

A61P 25/28 Drugs for disorders of the nervous system

Event Publications

12 July 2012 PCT application entered the National Phase

  PCT publication WO2011/079119 Priority application(s): WO2011/079119

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010336515-Intravaginal incontinence device

2010336509-Pteridinones as inhibitors of polo-like kinase